etoposide has been researched along with Diathesis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blackwell, S; Buchanan, M; Clark, RE; Crawford, J; Grichnik, JM; Hitchcock, MG; Jimenez, F; Kurtzberg, J | 1 |
Fields, LL; Maziarz, RT; White, CR | 1 |
Dann, EJ; Gillis, S; Rund, D | 1 |
Bairey, O; Blickstein, D; Hadar, H; Lahav, M; Prokocimer, M; Shaklai, M; Shaklai, S; Sulkes, J | 1 |
Kaplan, LD; Volberding, PA | 1 |
1 review(s) available for etoposide and Diathesis
Article | Year |
---|---|
Treatment of AIDS and its attendant malignancies.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Anemia; Antineoplastic Combined Chemotherapy Protocols; Disease Susceptibility; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Neutropenia; Sarcoma, Kaposi; Vinblastine; Vincristine; Zidovudine | 1989 |
2 trial(s) available for etoposide and Diathesis
Article | Year |
---|---|
Human recombinant stem-cell factor induces melanocytic hyperplasia in susceptible patients.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cell Adhesion Molecules; Dendrites; Disease Susceptibility; Etoposide; Follow-Up Studies; Hematopoietic Cell Growth Factors; Humans; Hyperpigmentation; Hyperplasia; Injections, Subcutaneous; Lung Neoplasms; Melanins; Melanocytes; Recombinant Proteins; Stem Cell Factor | 1995 |
Severe myelotoxicity of oral etoposide in heavily pretreated patients with non-Hodgkin's lymphoma or chronic lymphatic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Disease Progression; Disease Susceptibility; Etoposide; Female; Gastrointestinal Diseases; Humans; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Remission Induction; Salvage Therapy | 1996 |
2 other study(ies) available for etoposide and Diathesis
Article | Year |
---|---|
Rapid development of disseminated superficial porokeratosis after transplant induction therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease Susceptibility; Doxorubicin; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Porokeratosis; Prednisone; Skin; Vincristine; Whole-Body Irradiation | 1995 |
Selective discharge of patients with acute myeloid leukemia during chemotherapy-induced neutropenia.
Topics: Acute Disease; Adult; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Catheterization, Central Venous; Cross Infection; Cytarabine; Daunorubicin; Disease Susceptibility; Etoposide; Female; Fever; Humans; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Neutropenia; Patient Discharge; Safety; Treatment Outcome | 1996 |